Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention1: Test Group
Nardostachysjatamansi DC (Sumbul-ut-Teeb)
: After making fine powder, the capsules shall be prepared of 500 mg each
90 capsules shall be dispensed to the patients in the transparent polypack for 15 days with the instruction to take two capsules thrice a day
Control Intervention1: Control Group
Roasted wheat flour
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of both gender 2.Age group of 20 â?? 60 years 3.Non-Alcoholic Fatty liver Grade I (Mild) and II (Moderate) based on Ultrasonography 4.Mildly raised liver enzymes (SGPTup to 100 IU/L and SGOT up to 80 IU/L)
Exclusion criteria
Exclusion criteria: 1. Pregnancy and lactation 2. Fatty liver â?? Grade III(severe) and above, focal fatty liver cases and cirrhosis 3. Known cases of Hepatitis and other liver diseases 4. History of metabolic disorders like diabetes mellitus 5. History of alcoholism 6. Hypothyroidism 7. Cholelithiasis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Anorexia 2. Nausea 3. Dyspepsia 4. Pain / heaviness in right hypochondriac region 5. Increased body weight Timepoint: The subjective parameters will be assessed at 1, 15, 30, 45, 60 Day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Decrease in echogenicity of liver on ultrasonography from grade-I to grade-II OR grade-1 to grade-0 2. Decrease in level of liver enzymes a. SGPT 60 IU/L b. SGOT 50 IU/L Timepoint: The subjective parameters will be assessed at fortnightly visit, while the objective parameters at 0, 30, 60 days excluding USG abdomen which will be carried out before initiation and after the completion of trial. | — |
Countries
India
Contacts
Public ContactMursaleen Naseer
Aligarh Muslim University
Outcome results
None listed